Colgate Palmolive Co (CL) Stock Price & Analysis
Colgate Palmolive Co (CL) rose 0.74% to USD 90.75 as of July 25, 2026 at 01:12 UTC, according to Nexqual real-time market data.
CL last closed at USD 90.08; the session ranged USD 90–91.11 on volume of 2,540,171 shares. Market capitalization is —, with a 52-week range of USD 74.55–99.33 (NYQ). Source: Nexqual, July 25, 2026 at 01:12 UTC.
Key Statistics (as of July 25, 2026 at 01:12 UTC)
| Price | USD 90.75 |
|---|---|
| Change | ▲ 0.74% (up) |
| Previous Close | USD 90.08 |
| Open | USD 90 |
| Day Range | USD 90 – 91.11 |
| 52-Week Range | USD 74.55 – 99.33 |
| Volume | 2,540,171 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (CL)
Nexqual's technical model rates CL "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 01:12 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.54 (neutral) |
| vs SMA50 | Above (USD 90.56) |
| MACD | 0.16 (positive) |
Analyst Ratings (CL)
Wall Street analysts rate CL "Buy" based on 20 analysts, with a mean price target of USD 97.65 (range USD 85–110), per Nexqual as of July 25, 2026 at 01:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 20 |
| Mean Target | USD 97.65 |
| High Target | USD 110 |
| Low Target | USD 85 |
| Buy / Hold / Sell | 13 / 7 / 1 |
Earnings (CL)
| Next Earnings Date | 2026-07-31 |
|---|---|
| EPS Estimate | USD 0.95 |
| Revenue Estimate | $5.36B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.97 vs est 0.94 ▲ beat |
| 2025-12-31 | USD 0.95 vs est 0.91 ▲ beat |
| 2025-09-30 | USD 0.91 vs est 0.89 ▲ beat |
| 2025-06-30 | USD 0.92 vs est 0.89 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financials & Fundamentals (CL)
| Total Revenue | $20.80B |
|---|---|
| Revenue Growth (YoY) | +8.40% |
| Gross Margin | +60.06% |
| Operating Margin | +20.92% |
| Profit Margin | +10.04% |
| ROE | +363.58% |
| Debt / Equity | 1,640.54 |
| Current Ratio | 1.03 |
| Total Cash | $1.42B |
| Total Debt | $7.97B |
| Free Cash Flow | $3.32B |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financial Health Score (CL)
Nexqual rates Colgate Palmolive Co's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 01:12 UTC.
| Growth | Solid — Revenue +8% YoY (latest Q) |
|---|---|
| Profitability | Strong — Gross margin 60%, operating 21% |
| Balance Sheet | Critical — $1.42B cash vs $7.97B debt |
| Cash Flow | Strong — FCF $3.32B, 16% margin |
| Efficiency | Strong — ROE 364%, ROA 16.1% |
Ownership (CL)
| Insider Ownership | +0.14% |
|---|---|
| Institutional Ownership | +87.95% |
| Float | 750.71M |
| Short % of Float | +2.44% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Leadership (CL)
Colgate Palmolive Co is led by Noel R. Wallace (age 61), Chairman, CEO & President, per Nexqual as of July 25, 2026 at 01:12 UTC.
| Chairman, CEO & President | Noel R. Wallace (age 61) |
|---|---|
| Chief Financial Officer | Stanley J. Sutula (age 59) |
| COO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | Panagiotis Tsourapas (age 60) |
| Chief Operating Officer of Americas | Shane Grant (age 50) |
| Chief Technology Officer | Stephan Habif |
Major Backers & Investors (CL)
Notable institutional backers of Colgate Palmolive Co include Price (T.Rowe) Associates Inc, Morgan Stanley, Fidelity, according to Nexqual as of July 25, 2026 at 01:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Price (T.Rowe) Associates Inc | 4.22% |
| Morgan Stanley | 2.61% |
| Fidelity | 1.29% |
| Goldman Sachs | 1.18% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 17.32% |
| BlackRock | 10.41% |
| State Street | 7.17% |
| Geode Capital | 2.86% |
| BNY Mellon | 1.56% |
| Deutsche Bank AG | 1.49% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
From Colgate Palmolive Co's Latest SEC 10-K Filing (filed 2026-02-23)
Key Strengths & Strategy (as disclosed to the SEC)
- Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally.
- It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition.
- The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
- This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CLX | Clorox Company (The) | USD 95.55 | ▼ 0.22% |
| KMB | Kimberly-Clark Corporation | USD 109.7 | ▲ 0.75% |
| GIS | General Mills, Inc. | USD 36.03 | ▼ 2.38% |
| PEP | Pepsico, Inc. | USD 136.64 | ▲ 0.73% |
| EMR | Emerson Electric Company | USD 147.94 | ▲ 5.95% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:12 UTC. This page is informational and not investment advice.